Our products

eConsent

Ease of understanding for patients. Full visibility and automated control over the consent process for sponsors. Extend your clinical trial command and control center with Suvoda eConsent.

Patients
53%

Only 53% of patients understand the potential for placebos in clinical research from informed consent documents.i

Source: Frontiers in Medicine: "Patients’ knowledge about their involvement in clinical trials. A non-randomized controlled trial"

Comprehension
57%

57% of participants rated it very easy to understand their electronic informed consent form compared to 44% with paper forms i

Source: 2025 CISCRP Perceptions & Insights Study

Visibility
100%

Experience 100% visibility over consent and reconsent at all sites and for all patients

A PATIENT-CRITICAL PROCESS

Improve patient experience and comprehension. Reduce site burden. And decrease regulatory risk, delays, and expenses created by mid-trial consent requirements.

In today’s clinical studies for novel, life-changing therapeutics, informed consent isn’t just a first step in a patient’s trial journey. It is central to a patient’s understanding of study procedures and is a critical ethical requirement. And it is a process that must be repeated along the way, as the vast majority of protocol amendments require the patients to re-consent. The result is heightened risk of patient misunderstanding, regulatory non-compliance, heavier administrative burden, and increased study expense and duration.

When approximately 70% of the oncology studies we support have at least one protocol amendment, the patient experience and sponsor visibility of Suvoda eConsent make it a must-have tool for study and site teams—and their patients.

OUR PRODUCTS

eConsent

Full visibility and automated control. Extend your clinical trial command and control center with Suvoda’s integrated e-Consent

Trials conducted
900+

with 75% in oncology, rare disease, and CNS

Countries supported
65

with trial sites in thousands of locations

Client satisfaction
9/10

year after year, in our annual company survey

TOOLS FOR PATIENT COMPREHENSION

Powerful features that drive patient understanding and reduce regulatory risk.

Suvoda eConsent features robust functionality that gives patients the tools they need to understand study information, which often includes complex medical and legal terms and concepts. At the same time, the visibility over consent across all study sites and patients means sponsors have control over the full process to minimize delays and reduce the risk of a regulatory finding. 

 
 

Patient comprehension

  • Embedded videos and FAQs

  • In-document discussion threads

  • Cross-linked glossary

Flexible design

  • Electronic signature, wet ink upload, or print-and-sign consent

  • Can accommodate multiple consent types (subject, caregiver, legally authorized representative)

  • Can support multiple, separately timestamped signatures from a participant in a single consent form

  • Multilingual capability

  • Available on multiple devices—web-based, on-site, or patient device

SEAMLESS ARCHITECTURE

A connected experience, built on the Suvoda Platform.

With Suvoda eConsent, you can manage consent seamlessly on the Suvoda Platform—a unified clinical trial platform purpose-built for the mission-critical, time-sensitive moments that keep your trial moving. Across the Suvoda Platform, sponsors, sites, and patients can move through the trial experience with fewer disconnected tools and a clearer view of what happens next.

 

For patients: one app for the patient journey

Patients can complete consent remotely, from home, through the Suvoda web app. With one login, they can also respond to questionnaires, access payments, manage travel, and more—all within the same app. A connected experience helps simplify study activities and support engagement throughout the trial.

For sites: one platform, intuitive workflows

Bring consent into the same intuitive environment used for study activities. Protocol-guided workflows help site teams follow the right steps at the right time—reducing the risk of manual errors, minimizing system switching, and simplifying day-to-day work.

For sponsors: one command center, real-time visibility

Manage consent as part of the same Suvoda Platform used to oversee trial operations. Real-time reporting gives study teams visibility into consent status across sites and participants, while connected workflows help teams spot what needs attention and act with confidence.

One platform for study teams. One connected experience for patients. 

INTUITIVE INTERFACE

Suvoda eConsent brings a clear, intuitive consent experience to the Suvoda Platform.

Study teams can manage consent within the broader study environment, with task-focused workflows that help them find the right tools and focus on the next step. Participants can complete consent in the Suvoda web app and access other study activities there with a single login.

The result: an eConsent experience that feels connected—for study teams and participants alike. 

INTEGRATED REPORTING

Gain real-time visibility to subjects’ consent status across all your sites, right in the Suvoda Platform.

We know that if you can’t measure it, you can’t manage it. That’s why Suvoda eConsent maximizes transparency and visibility, compiling critical consent data and presenting it through our robust reporting. 

Identify, in real-time, the sites that are lagging in getting patients to consent to the latest versions. Digitally archive consent documents for compliance and audit. With full access to eConsent reports, study teams and field monitors can then take early corrective actions with outlier sites and verify consents were done properly without the need for physical visits. The result? Increased regulatory compliance and reduced risk of excluded patients and discarded data at the end of the trial. 

At the very first presentation when we saw the system, is it strange to say that it seemed very beautiful? And very easy to use. The flow makes a lot of sense. Users can figure it out. The reports in particular are great, and I can control what I want to see.”
Niv Alon, Head of PMO, Galmed Pharmaceuticals

eConsent FAQs

View the full eConsent FAQ list →

Related Insights

IRT: The key to wisely-managed patient interactions

A UNIFIED CLINICAL TRIAL PLATFORM

Powering the patient's digital journey in life-changing clinical trials

Embrace today’s clinical trial complexities with a market-leading, real-time software platform to drive confident decisions and calm action.
Learn more
Client Services

Broad perspective. Keen insight. Calm guidance.

See how we support you
Integration

Seamless technology in complex ecosystems

See how we bring it all together

Request a demo